Teleflex vascular access device safety and performance registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The registry will enroll patients who receive a range of Teleflex vascular access devices—including central venous, hemodialysis, midline, peripheral, and arterial catheters—and collect standardized clinical data during routine care. Data collection is designed to meet Level 3 MDCG 2020-6 standards and will capture device performance, complications, and clinical outcomes. Participation requires informed consent and occurs at participating hospitals where device placement and follow-up happen per usual practice. This is an observational registry and does not direct specific treatments or procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
* Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
* Subjects is able to read and understand English or Spanish languages

Exclusion Criteria:

* Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
* Subject was previously failed screening or was enrolled in this clinical Registry.
* Subject is imprisoned
* Subject is cognitively impaired and unable to provide informed consent

Where it's running

• Huntsville Hospital
  Huntsville, Alabama, United States Recruiting
• Loma Linda University Health
  Loma Linda, California, United States Recruiting
• Tufts Medical Center
  Boston, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Samson Odeyemi
• Email: samson.odeyemi@teleflex.com
• Phone: 9402904684

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Treatment for liver metastases from colorectal cancer using a combination of therapies

  This study is testing if a new combination of treatments for liver cancer from colorectal cancer can help patients live longer compared to the standard treatment they would usually receive.

  Recruiting Phase 3 The Netherlands Cancer Institute · Amsterdam · NCT06857773

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Orsiro Mission 48‑mm sirolimus‑coated coronary stent for long coronary blockages

  This study will try a 48‑mm Orsiro sirolimus‑coated coronary stent in adults who have long (36–44 mm) atherosclerotic blockages in native coronary arteries.

  Recruiting at 10 sites Teleflex · Concord, California and 22 other locations · NCT06779630

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.